NCT03146676 The Ohio State University Dermatology Biorepository
| NCT ID | NCT03146676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Hidradenitis Suppurativa |
| Study Type | OBSERVATIONAL |
| Enrollment | 175 participants |
| Start Date | 2017-04-19 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 175 participants in total. It began in 2017-04-19 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Eligibility Criteria
Inclusion Criteria: * Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol * Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals * Willingness to participate in a research study. Exclusion Criteria: * Inability to provide informed consent
Contact & Investigator
Benjamin Kaffenberger, MD
PRINCIPAL INVESTIGATOR
Dermatologist
Frequently Asked Questions
Who can join the NCT03146676 clinical trial?
This trial is open to participants of all sexes, studying Hidradenitis Suppurativa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03146676 currently recruiting?
Yes, NCT03146676 is actively recruiting participants. Contact the research team at alison.wandling@osumc.edu for enrollment information.
Where is the NCT03146676 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT03146676 clinical trial?
NCT03146676 is sponsored by Ohio State University. The principal investigator is Benjamin Kaffenberger, MD at Dermatologist. The trial plans to enroll 175 participants.